DOI:
10.1055/s-00000102
Zeitschrift für Palliativmedizin
LinksClose Window
References
Reungwetwattana T, Nakagawa K, Cho BC. et al.
CNS Response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated egfr-mutated advanced non-small-cell lung cancer.
J Clin Oncol 2018;
36: 3290-3297
DOI: 10.1200/JCO.2018.78.3118.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.